Sunshine Biopharma Inc. (SBFM): Price and Financial Metrics
SBFM Price/Volume Stats
| Current price | $0.81 | 52-week high | $140.00 |
| Prev. close | $0.93 | 52-week low | $0.75 |
| Day low | $0.75 | Volume | 11,791,174 |
| Day high | $0.89 | Avg. volume | 865,458 |
| 50-day MA | $6.02 | Dividend yield | N/A |
| 200-day MA | $26.63 | Market Cap | 804.26K |
SBFM Stock Price Chart Interactive Chart >
Sunshine Biopharma Inc. (SBFM) Company Bio
Sunshine Biopharma, Inc. engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. Its products include treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Pointe-Claire, Canada.
Latest SBFM News From Around the Web
Below are the latest news stories about SUNSHINE BIOPHARMA INC that investors may wish to consider to help them evaluate SBFM as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time to dive into the biggest pre-market stock movers as we check out all of the hottest trading news for Tuesday morning! |
Sunshine Biopharma Moves Principal Office to New York CityNEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM”) (the “Company”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has moved its headquarters to New York City. The Company’s Head Office is now located at 1177 Avenue of the Americas, 5th Floor, New York, NY 10036 (Tel: 332-216-1147). The Company will maintain a satellite office at its previous hea |
Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key AcquisitionMONTREAL, QC / ACCESSWIRE / November 13, 2023 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today ... |
Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid ComplianceSunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has received a 180-day extension, until March 18, 2024, to achieve compliance with the Nasdaq $1.00 minimum bid price rule. |
It's Down 26% But Sunshine Biopharma, Inc. (NASDAQ:SBFM) Could Be Riskier Than It LooksTo the annoyance of some shareholders, Sunshine Biopharma, Inc. ( NASDAQ:SBFM ) shares are down a considerable 26% in... |
SBFM Price Returns
| 1-mo | -85.81% |
| 3-mo | -96.81% |
| 6-mo | -97.47% |
| 1-year | -98.72% |
| 3-year | -99.97% |
| 5-year | -99.98% |
| YTD | -97.02% |
| 2023 | -57.58% |
| 2022 | -94.53% |
| 2021 | 272.61% |
| 2020 | 57.00% |
| 2019 | -96.88% |
Loading social stream, please wait...